Silverberg Bernstein Capital Management LLC Chroma Dex Corp. Transaction History
Silverberg Bernstein Capital Management LLC
- $109 Billion
- Q3 2024
A detailed history of Silverberg Bernstein Capital Management LLC transactions in Chroma Dex Corp. stock. As of the latest transaction made, Silverberg Bernstein Capital Management LLC holds 83,257 shares of CDXC stock, worth $477,895. This represents 0.28% of its overall portfolio holdings.
Number of Shares
83,257
Previous 82,157
1.34%
Holding current value
$477,895
Previous $224 Million
35.49%
% of portfolio
0.28%
Previous 0.22%
Shares
3 transactions
Others Institutions Holding CDXC
# of Institutions
87Shares Held
16.5MCall Options Held
91.7KPut Options Held
18.9K-
Vanguard Group Inc Valley Forge, PA3.39MShares$19.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.12MShares$17.9 Million0.0% of portfolio
-
Tieton Capital Management, LLC Yakima, WA2.97MShares$17 Million4.5% of portfolio
-
Iconiq Capital, LLC San Francisco, CA1.3MShares$7.44 Million0.07% of portfolio
-
Geode Capital Management, LLC Boston, MA1.13MShares$6.5 Million0.0% of portfolio
About ChromaDex Corp.
- Ticker CDXC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,350,896
- Market Cap $392M
- Description
- ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...